33-year-old female with history of PNET status post Whipple (11/2015) with hepatic masses. ABDOMEN:LIVER, BILIARY TRACT: Susceptibility artifact from coils in the right hepatic lobe, cholecystectomy clips, and common bile duct stent.Unchanged, 6.2 x 6.0 cm arterially enhancing mass in hepatic segment eight with a central scar that is T2 hyperintense and demonstrates delayed enhancement compatible with focal nodular hyperplasia. A smaller, adjacent segment 8 arterially enhancing lesion is also unchanged and may represent a focal nodular hyperplasia. Redemonstrated are segment 3 and segment 6 lesions compatible with hemangiomas, unchanged. Two segment 2 lesions are again noted compatible with hemangiomas, unchanged.Moderate intrahepatic biliary ductal dilation in the left liver lobe, increased from the prior examination. Cavernous transformation of the portal vein is again noted. Paraesophageal and gastric varices. SPLEEN: Spleen size is top normal. Splenic vein thrombosis. PANCREAS: Postsurgical changes in the head of the pancreas. No pancreatic ductal dilatation.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Bilateral T2 hyperintense cyst. No hydronephrosis or mass lesion.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: Diastasis of the abdominal musculature.OTHER: No significant abnormality noted.PELVIS:UTERUS, ADNEXA: No significant abnormality noted.BLADDER: No significant abnormality noted.LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: Small amount of free fluid in the pelvis. Bilateral adnexal cysts likely physiologic.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Multiple hepatic lesions with the largest lesion in hepatic segment 8, unchanged and compatible with FNH. 2.Additional hepatic lesions are unchanged as detailed above. 3.Interval increase in intrahepatic ductal dilation, raises concern for stent patency; correlation with patient's clinical history and laboratory values recommended. 4.Other findings as above. 